Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCloudtag Inc Regulatory News (CTAG)

  • There is currently no data for CTAG

Operational Update & Subscription for £470,000

16 Jun 2016 07:00

RNS Number : 3341B
CloudTag Inc.
16 June 2016
 

16 June 2016

CloudTag Inc.("CloudTag" or "the Company")

Operational Update & Subscription for £470,000

 

CloudTag (CTAG: LN), the company that brings personal monitoring to the health, wellbeing and fitness markets, is pleased to announce an operational update and to announce it has raised £470,000 by way of a subscription for new ordinary shares.

 

Operational Update

 

Further to the Commercial Update made by the Company on 9th June 2016, announcing the progress made with our European distribution partner and various high street and online retailers, CloudTag is also currently in the process of recruiting 3 senior executives to drive sales to consumer markets in the UK and Europe and facilitate delivery of the Company's first product - the CloudTag Track. 

These executives will have direct and current experience in the wearable technology and consumer electronics industries and proven track records. Specifically, these roles include both a UK & Ireland Sales Director and a European Sales Director who will be tasked with delivering products to market and subsequently driving sales. The Company is also recruiting a Business Development Director who will be tasked with driving and delivering the B2C and B2B strategy as outlined by the Company's CEO, Amit Ben-Haim in the Company's Final Results statement of March 2016.

Additionally, the Company continues to focus its R&D efforts on creating new and unique technologies to maintain CloudTag's differentiation in the fast moving marketplace. In order to facilitate these efforts, the Company is in the process of strengthening its team by hiring specialists in embedded systems electronics, mechanical engineering, and product and industrial design. The Company is also seeking to recruit user experience market specialists, mathematicians and "big data" scientists as well as additional manufacturing engineers and quality assurance specialists who will work closely with the international quality assurance agency which we are currently in the process of engaging.

Meanwhile, in the lead up to full commercial release of the product in the UK and Europe, CloudTag is in the process of moving manufacturing from its current low volume production partner in Taiwan, which was suitable for production of rapid, low-cost test batches; to new production partners also based in the Far East with mass production capabilities and which hold the following ISOs: 13485, 14000 and 9000. 

The board will carefully monitor the Company's working capital position in light of its plans to accelerate the business outlined in this announcement. The Company has been successful in raising additional working capital in recent months and we are pleased to announce a further fundraising. The Board will retain a flexible approach to implementing its plans to ensure that sufficient working capital is available at all times.

 

Subscription for £470,000

 

Additionally, the Company announces that it has raised £470,000 net of expenses through the issue of 7,768,596 new ordinary shares at price of 6.05 pence per share ("Shares"). 

 

Application will be made for the admission of 7,768,596 new ordinary shares to trading on AIM and it is expected that dealings in the Shares will commence on or around 21 June 2016. The Shares will rank pari passu with the Company's existing ordinary shares.

 

Following the issue of the Shares, the total number of ordinary shares in issue is 323,348,213. This number may be used by shareholders as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company.

 

Enquiries

 

CloudTag Inc.

Amit Ben-Haim

 

+1 345 949 45 44

contact@cloudtag.com

Cairn Financial Advisers LLP (Nominated Adviser)

Tony Rawlinson / Jo Turner

 

+44 (0) 20 7148 7900

Tavistock Communications Limited (Financial PR)

Mike Bartlett / Andrew Dunn

+44 (0) 20 7920 3150

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCEAPKSFLDKEFF
Date   Source Headline
5th Sep 201611:00 amRNSSecond Price Monitoring Extn
5th Sep 20169:05 amRNSSecond Price Monitoring Extn
5th Sep 20169:00 amRNSPrice Monitoring Extension
2nd Sep 20164:40 pmRNSSecond Price Monitoring Extn
2nd Sep 20164:35 pmRNSPrice Monitoring Extension
2nd Sep 20164:02 pmRNSMovement in Share Price and Update
16th Aug 201611:16 amRNSHolding(s) in Company
10th Aug 20167:00 amRNSFundraise of £580,000
8th Aug 20167:00 amRNSBinding Heads of Terms Signed with US Partner
5th Aug 20161:28 pmRNSCorrection: Holding(s) in Company
4th Aug 20164:08 pmRNSHolding(s) in Company
1st Aug 20167:00 amRNSAppointment of Chief Creative Officer
18th Jul 20165:13 pmRNSHolding(s) in Company
14th Jul 201611:32 amRNSHolding(s) in Company
14th Jul 20167:00 amRNSFundraise of £800,000
12th Jul 20167:00 amRNSIssue of Equity
6th Jul 20167:00 amRNSGrant of Options and Warrants
5th Jul 20164:40 pmRNSSecond Price Monitoring Extn
5th Jul 20164:35 pmRNSPrice Monitoring Extension
1st Jul 20164:10 pmRNSHolding(s) in Company
28th Jun 20167:00 amRNSHalf-year Report
22nd Jun 20161:10 pmRNSHolding(s) in Company
16th Jun 20167:00 amRNSOperational Update & Subscription for £470,000
15th Jun 20164:21 pmRNSHolding(s) in Company
9th Jun 20167:00 amRNSCommercial Update and Subscription
31st May 201610:07 amRNSMovement in Share Price
10th May 201610:06 amRNSHolding(s) in Company
3rd May 20167:00 amRNSFundraising £50,000 & Conversion of Loan Notes
29th Apr 20164:48 pmRNSIssue of Equity
26th Apr 20164:03 pmRNSResult of AGM
12th Apr 20163:59 pmRNSCorrection: Fundraise of £171,430
11th Apr 20167:00 amRNSFundraise of £171,430
7th Apr 20164:58 pmRNSHolding(s) in Company
5th Apr 20166:01 pmRNSFundraise of £60,000
31st Mar 20167:00 amRNSHolding(s) in Company
30th Mar 20165:23 pmRNSPosting of Annual Report
30th Mar 20167:00 amRNSDirector/PDMR Shareholding
24th Mar 20167:00 amRNSFundraise of £112,000
23rd Mar 20167:00 amRNSFinal Results
21st Mar 20167:00 amRNSFundraise of £225,400
16th Mar 201611:03 amRNSFundraise of £228,000
16th Mar 20169:28 amRNSHolding(s) in Company
7th Mar 20167:00 amRNSFundraise of £65,000
29th Feb 20164:19 pmRNS£215,000 Fundraising
25th Jan 20167:00 amRNSUS$5.2 Million Distribution Agreement
22nd Jan 20167:00 amRNSISPO Exhibition
21st Jan 20167:00 amRNS£250,000 Fundraising
15th Jan 20167:00 amRNSOperational Update & Convertible Loan Facility
6th Jan 20168:03 amRNSFirst Product Launch
31st Dec 20157:00 amRNSIssue of Equity

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.